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ABSTRACT 
Flavokawain B (FKB) is a naturally occurring chalcone that can be isolated through the root extracts 
of the kava-kava plant (Piper methysticum). It can also be synthesized chemically to increase the 
yield. This compound is a promising candidate as a biological agent, as it is reported to be involved in 
a wide range of biological activities. Furthermore, FKB was reported to have antitumorigenic effects 
in several cancer cell lines in vitro. However, the in vivo antitumor effects of FKB have not been 
reported on yet. Breast cancer is one of the major causes of cancer-related deaths in the world 
today. Any potential treatment should not only impede the growth of the tumor, but also modulate 
the immune system efficiently and inhibit the formation of secondary tumors. As presented in our 
study, FKB induced apoptosis in 4T1 tumors in vivo, as evidenced by the terminal deoxynucleotidyl 
transferase dUTP nick end labeling and hematoxylin and eosin staining of the tumor. FKB also 
regulated the immune system by increasing both helper and cytolytic T-cell and natural killer cell 
populations. In addition, FKB also enhanced the levels of interleukin 2 and interferon gamma but 
suppressed interleukin 1B. Apart from that, FKB was also found to inhibit metastasis, as evaluated by 
clonogenic assay, bone marrow smearing assay, real-time polymerase chain reaction, Western blot, 
and proteome profiler analysis. All in all, FKB may serve as a promising anticancer agent, especially in 
treating breast cancer. 
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